EBV-MS
Targeting the Epstein-Barr virus to treat and prevent MS (EBV-MS) is a ground-breaking Horizon Europe-funded research project with leading universities and hospitals in Europe and the USA. We are aiming to unveil the role of the Epstein-Barr virus (EBV) in the onset and progression of the Multiple Sclerosis (MS) disease.
About the research project
The aim of the project, led by the University of Bergen, is to understand why only a few EBV infected people develop MS, and define the underlying mechanism of this process. The project will also investigate whether targeting the EBV infection with antiviral treatments can improve the disease course or stop disease progression.
Project managers
- Kjell-Morten Myhr, Project Manager, e-mail: kjell-morten.myhr@uib.no
- Øivind F. Grytten Torkildsen, Deputy Project Coordinator, e-mail: Oivind.Torkildsen@uib.no
European Union support
This project has received funding from the European Union’s Horizon Europe Research and Innovation Actions under grant no. 101136991 (EBV-MS). Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
Featured
-
Meeting with the Scientific Advisory Board of the EBV-MS Project
On 20 June 2026, the EBV-MS consortium met with its Scientific Advisory Board (SAB) to present progress and show how expert feedback is shaping our efforts to understand and target Epstein-Barr Virus in the context of multiple sclerosis (MS). From clinical trials and immunology to bioinformatics and predictive modelling, each work package shared exciting developments and next steps. -
Nobel Symposium on Multiple Sclerosis Highlights EBV Link
For the first time, a Nobel Symposium has been dedicated to Multiple Sclerosis (MS), bringing global experts to Stockholm on June 2–5, 2025. Hosted at the Karolinska Institutet, the symposium - “Multiple Sclerosis: From Molecular Mechanisms to Disease-Modifying Treatments” - features leading researchers from Europe and the U.S., including several key members of the EBV-MS consortium.
Events
People
Project manager
Kjell-Morten Myhr Project manager, e-mail kjell-morten.myhr@uib.no, tel. +47 55976031 / +47 41447868
Øivind F. Grytten Torkildsen Deputy Project Coordinator, e-mail: Oivind.Torkildsen@uib.no
Other EBV-MS Project office contacts
Yamila Torres Cleuren Scientific Project Manager, e-mail: Yamila.cleuren@uib.no, tel: +47 55585431
Mona Machrouh Scientific Project Manager, e-mail: mona.machrouh@uib.no, tel: +47 55589111
Hege Høiland Project Financial Manager, e-mail: hege.hoiland@uib.no, tel: +47 55584974
Janniche Torsvik Project coordinator, e-mail: janniche.torsvik@uib.no